Free Trial
CVE:VM

Voyageur Pharmaceuticals (VM) Stock Price, News & Analysis

Voyageur Pharmaceuticals logo
C$0.10 -0.01 (-9.09%)
As of 09:30 AM Eastern

About Voyageur Pharmaceuticals Stock (CVE:VM)

Advanced

Key Stats

Today's Range
C$0.10
C$0.10
50-Day Range
C$0.10
C$0.18
52-Week Range
C$0.10
C$0.36
Volume
20,000 shs
Average Volume
78,115 shs
Market Capitalization
C$17.95 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Voyageur Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

VM Stock News Headlines

SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a $1.75 trillion IPO - larger than Saudi Aramco and any tech offering in history. CNBC calls it 'the big market event of 2026.' According to former tech executive and angel investor Jeff Brown, there's a way to claim a stake before the public filing drops, starting with as little as $500.tc pixel
See More Headlines

VM Stock Analysis - Frequently Asked Questions

Voyageur Pharmaceuticals' stock was trading at C$0.17 at the beginning of 2026. Since then, VM stock has decreased by 41.2% and is now trading at C$0.10.

Shares of VM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Voyageur Pharmaceuticals investors own include GFG Resources (GFG), Pine Cliff Energy (PNE), Tamarack Valley Energy (TVE), Capstone Copper (CS), Calibre Mining (CXB) and Mawson Gold (MAW).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
CVE:VM
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$1.66 million
Net Margins
-10,796.29%
Pretax Margin
N/A
Return on Equity
-313.14%
Return on Assets
-30.77%

Debt

Debt-to-Equity Ratio
6.05
Current Ratio
0.18
Quick Ratio
0.84

Sales & Book Value

Annual Sales
C$30.96 thousand
Price / Sales
579.72
Cash Flow
C$0.00 per share
Price / Cash Flow
35.00
Book Value
C$0.00 per share
Price / Book
27.03

Miscellaneous

Outstanding Shares
179,476,000
Free Float
N/A
Market Cap
C$17.95 million
Optionable
Not Optionable
Beta
1.07
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report

This page (CVE:VM) was last updated on 5/5/2026 by MarketBeat.com Staff.
From Our Partners